Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas W Prior

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
The New England Journal of Medicine|May 6, 2005
Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)Heather Hampel, Wendy L Frankel, Edward Martin, et al.
The Journal of Molecular Diagnostics : JMD|November 16, 2020
Characterization of Reference Materials for Spinal Muscular Atrophy Genetic Testing: A Genetic Testing Reference Materials Coordination Program Collaborative ProjectThomas W Prior, Pinar Bayrak-Toydemir, Ty C Lynnes, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 19, 2005
Technical standards and guidelines: venous thromboembolism (Factor V Leiden and prothrombin 20210G >A testing): a disease-specific supplement to the standards and guidelines for clinical genetics laboratoriesElaine B Spector, Wayne W Grody, Carla J Matteson, et al.
Viruses|September 28, 2021
Characterization of Prion Disease Associated with a Two-Octapeptide Repeat InsertionNicholas Brennecke, Ignazio Cali, Tze How Mok, et al.
American Journal of Medical Genetics. Part A|August 5, 2010
Unexpected detection of dystrophin gene deletions by array comparative genomic hybridizationCatherine E Cottrell, Thomas W Prior, Robert Pyatt, et al.
Journal of Neuromuscular Diseases|November 19, 2016
Spinal Muscular Atrophy Biomarker Measurements from Blood Samples in a Clinical Trial of Valproic Acid in Ambulatory AdultsSamantha R Renusch, Sean Harshman, Hongyang Pi, et al.
Pediatric Neurology|July 7, 2019
Impact of Age and Motor Function in a Phase 1/2A Study of Infants With SMA Type 1 Receiving Single-Dose Gene Replacement TherapyLinda P Lowes, Lindsay N Alfano, W David Arnold, et al.
Neurology|March 21, 2014
Congenital lethal motor neuron disease with a novel defect in ribosome biogenesisRussell J Butterfield, Tamara J Stevenson, Lingyan Xing, et al.
JAMA|November 17, 2005
Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposisKevin Sweet, Joseph Willis, Xiao-Ping Zhou, et al.
Plos One|May 15, 2009
Phase II open label study of valproic acid in spinal muscular atrophyKathryn J Swoboda, Charles B Scott, Sandra P Reyna, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
The New England Journal of Medicine|May 6, 2005
Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)Heather Hampel, Wendy L Frankel, Edward Martin, et al.
The Journal of Molecular Diagnostics : JMD|November 16, 2020
Characterization of Reference Materials for Spinal Muscular Atrophy Genetic Testing: A Genetic Testing Reference Materials Coordination Program Collaborative ProjectThomas W Prior, Pinar Bayrak-Toydemir, Ty C Lynnes, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 19, 2005
Technical standards and guidelines: venous thromboembolism (Factor V Leiden and prothrombin 20210G >A testing): a disease-specific supplement to the standards and guidelines for clinical genetics laboratoriesElaine B Spector, Wayne W Grody, Carla J Matteson, et al.
Viruses|September 28, 2021
Characterization of Prion Disease Associated with a Two-Octapeptide Repeat InsertionNicholas Brennecke, Ignazio Cali, Tze How Mok, et al.
American Journal of Medical Genetics. Part A|August 5, 2010
Unexpected detection of dystrophin gene deletions by array comparative genomic hybridizationCatherine E Cottrell, Thomas W Prior, Robert Pyatt, et al.
Journal of Neuromuscular Diseases|November 19, 2016
Spinal Muscular Atrophy Biomarker Measurements from Blood Samples in a Clinical Trial of Valproic Acid in Ambulatory AdultsSamantha R Renusch, Sean Harshman, Hongyang Pi, et al.
Pediatric Neurology|July 7, 2019
Impact of Age and Motor Function in a Phase 1/2A Study of Infants With SMA Type 1 Receiving Single-Dose Gene Replacement TherapyLinda P Lowes, Lindsay N Alfano, W David Arnold, et al.
Neurology|March 21, 2014
Congenital lethal motor neuron disease with a novel defect in ribosome biogenesisRussell J Butterfield, Tamara J Stevenson, Lingyan Xing, et al.
JAMA|November 17, 2005
Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposisKevin Sweet, Joseph Willis, Xiao-Ping Zhou, et al.
Plos One|May 15, 2009
Phase II open label study of valproic acid in spinal muscular atrophyKathryn J Swoboda, Charles B Scott, Sandra P Reyna, et al.
Pageof 9